Wednesday, July 8, 2026
🇺🇸 FDA

biotech · Chronic Hepatitis B · Chronic Hepatitis B Infection · ALGS

Aligos Therapeutics

Aligos Therapeutics patent portfolio — 32 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
1 Corporate Dr, South San Francisco, California 94080, US HQ
2018 Founded
98 Employees
Public company Type
ALGS · NYSE Ticker
Company details
Status
Public
HQ
1 Corporate Dr, South San Francisco, California 94080, US
Founded
2018
Employees
98
Programs
14
Drugs
10
Patents
32
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Patents

Aligos Therapeutics patents

32 pharmaceutical patents indexed for Aligos Therapeutics. 0 expire within 24 months.

Aligos Therapeutics has 32 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

32 patents

Patent portfolio

  1. US 12384779

    Bicyclic compounds

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12252481

    Anti-viral compounds

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12180192

    Modulators of THR-β and methods of use thereof

    Expires Mon Dec 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12129469

    Modified short interfering nucleic acid (siNA) molecules and uses thereof

    Expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12065428

    Anti-viral compounds

    Expires Mon Aug 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12018015

    Methods and compositions for targeting PD-L1

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11957683

    Bicyclic compounds

    Expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11952374

    Bicyclic compounds

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11952365

    Anti-viral compounds

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11939581

    Methods and compositions for targeting PD-L1

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11858913

    Bicyclic pyridazinones and methods of use thereof

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11851422

    Anti-viral compounds

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11845752

    Substituted imidazo[1,5-a]pyrazines for the treatment of hepatitis B

    Expires Mon Dec 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11840532

    Modulators of THR-β and methods of use thereof

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11820773

    Tricyclic compounds

    Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11793815

    Oxindoles and methods of use thereof

    Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11786532

    2-pyridones and methods of use thereof

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11787833

    Modified cyclic dinucleoside compounds as sting modulators

    Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11771680

    Pyrrole compounds

    Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11760761

    Methods and compositions for targeting PD-L1

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11760764

    Methods and compositions for targeting PD-L1

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11613750

    Methods of reducing virus molecule levels

    Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11591341

    Bicyclic and tricyclic compounds

    Expires Mon Feb 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11549110

    Modified short interfering nucleic acid (siNA) molecules and uses thereof

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11466274

    Modified gapmer oligonucleotides and methods of use

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11464783

    Heterocyclic compounds

    Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11198699

    Compounds targeting PRMT5

    Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11191747

    Pyrrole compounds

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11166976

    S-antigen transport inhibiting oligonucleotide polymers and methods

    Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11136321

    Tricyclic compounds

    Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11091467

    Modulators of THR-β and methods of use thereof

    Expires Mon Aug 12 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11033556

    Bicyclic sulfonamides

    Expires Mon Jun 10 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Aligos Therapeutics have?

32 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Aligos Therapeutics patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.